Search
Protocol No.: HZNP-TEP-305
- Title
- A Phase 3, Randomized, Double-masked, Placebo-controlled, Parallel-group, Multicenter Trial to Evaluate the Efficacy, Safety and Tolerability of Subcutaneous Teprotumumab in Participants with Moderate-to-Severe Active Thyroid Eye Disease
- Principal Investigator
- Nguyen, John
- Phase
- III
- Age Group
- Adult
- Applicable Disease Site
- Other
- Participating Institutions
- Eye Institute
- West Virginia University
- Contacts
- Athena Echols
- Clinical Trials Coordinator
- Phone: +1 304-598-6977
- Email: athena.sparks@wvumedicine.org
- Christina Sundar, CRC
- Clinical Research Coordinator
- Phone: +1 304-598-6956
- Email: christina.sundar1@wvumedicine.org
- Emalee Taylor
- Certified Ophthalmic Assistant
- Email: emalee.taylor@wvumedicine.org